Literature DB >> 7589059

Changes in the use of antibacterial drugs in the countries of central and eastern Europe.

R A Kiivet1, V Bíba, D Enache, V Foltan, J Gulbinovic, N Oltványi, A Orazem, M Popova, L Stika.   

Abstract

Use of systemic antibacterial drugs in the countries of central and eastern Europe (CCEE) has been studied using the defined daily doses (DDD) methodology. For the comparison, national wholesale data from Bulgaria, the Czech Republic, Estonia, Hungary, Lithuania, Slovakia, Slovenia and Romania for the years 1989 and 1992 were used, i.e. for the years before and after the rapid sociopolitical changes in these countries. Substantial differences in the patterns of antibacterial drug use between countries as geographically and economically similar as the CCEE were observed. The general sales of antibiotics varied almost twofold among the CCEE and had decreased in most of the CCEE during the study period. The proportion of tetracyclines in the sales of 1992 ranged from 10% in Slovenia to 49% in Estonia, and that of broad-spectrum penicillins from 6% in Estonia to 40% in Slovenia. The use of narrow-spectrum penicillins varied within the range of 4% in Bulgaria to 38% in Slovakia, and had decreased during the study years in all countries. Aminoglycosides accounted for 5-12% of all antibacterials in Bulgaria, Estonia, Lithuania, Romania and Slovakia in the study period, and these countries, with the exception of Slovakia, also had a high consumption of chloramphenicol. In 1992, by far the most popular antiinfectives in the CCEE were doxycycline, ampicillin and co-trimoxazole, which ranked among the top ten drugs in all countries studied.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7589059     DOI: 10.1007/BF00198316

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  11 in total

1.  Cephalosporin and aminoglycoside utilization in different parts of the world.

Authors:  C R Kumana; K Y Li; M Kou; S C Chan
Journal:  J Antimicrob Chemother       Date:  1989-12       Impact factor: 5.790

2.  The use of drugs in Estonia compared to the Nordic countries.

Authors:  R A Kiivet; U Bergman; F Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 3.  Report of a symposium on use and abuse of antibiotics worldwide.

Authors:  C M Kunin; K S Johansen; A M Worning; F D Daschner
Journal:  Rev Infect Dis       Date:  1990 Jan-Feb

4.  Clinical judgement and antibiotic use in general practice.

Authors:  J G Howie
Journal:  Br Med J       Date:  1976-10-30

Review 5.  Estimating worldwide current antibiotic usage: report of Task Force 1.

Authors:  N F Col; R W O'Connor
Journal:  Rev Infect Dis       Date:  1987 May-Jun

Review 6.  Resistance of bacteria to antibacterial agents: report of Task Force 2.

Authors:  T F O'Brien
Journal:  Rev Infect Dis       Date:  1987 May-Jun

7.  An international study on the occurrence of multiresistant bacteria and aminoglycoside consumption patterns.

Authors:  K S Johansen; M Storgaard; N Carstensen; U Frank; F Daschner
Journal:  Infection       Date:  1988 Sep-Oct       Impact factor: 3.553

8.  The measurement of drug consumption. Drugs for diabetes in Northern Ireland, Norway and Sweden.

Authors:  U Bergman; P Elmes; M Halse; T Halvorsen; H Hood; P K Lunde; F Sjöqvist; O L Wade; B Westerholm
Journal:  Eur J Clin Pharmacol       Date:  1975-02-28       Impact factor: 2.953

9.  Therapeutic traditions in Northern Ireland, Norway and Sweden: I. Diabetes. WHO Drug Utilization Research Group (DURG).

Authors:  K Griffiths; D G McDevitt; M Andrew; I Baksaas; A Helgeland; J Jervell; P K Lunde; K Oydvin; I Agenäs; U Bergman
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

10.  Therapeutic traditions in Northern Ireland, Norway and Sweden: II. Hypertension. WHO Drug Utilization Research Group (DURG).

Authors:  K Griffiths; D G McDevitt; M Andrew; I Baksaas; A Helgeland; J Jervell; P K Lunde; K Oydvin; I Agenäs; U Bergman
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

View more
  2 in total

1.  Antibiotic resistance in Shigella and Salmonella in a region of Lithuania.

Authors:  G Jensen; D A Wandall; K Gaarslev; S Panavas; E Gutschik
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-11       Impact factor: 3.267

2.  Consumption of anti-infective drugs in Bulgaria for the period from 1979 to 1994.

Authors:  M Popova; P Popova; G Guencheva
Journal:  Pharm World Sci       Date:  1997-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.